Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells

International Journal of Oncology

Volumn 37, Issue 2, 2010, Pages 249-256

  Georges, Rania ^a   Adwan, Hassan ^a   Zhivkova, Maria ^a   Eyol, Ergül ^a   Bergmann, Frank ^b   Berger, Martin R ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CC531 cells; Co culture; Hepatocytes; Hoxc8; SIBLINGs

Indexed keywords

BONE SIALOPROTEIN; COMPLEMENTARY DNA; GELATINASE B; MATRILYSIN; OSTEOPONTIN; RNA; TRANSCRIPTION FACTOR RUNX2; HOMEODOMAIN PROTEIN; INTEGRIN BINDING SIALOPROTEIN; INTEGRIN-BINDING SIALOPROTEIN; RUNX2 PROTEIN, RAT; SIALOGLYCOPROTEIN; SPP1 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; COLON ADENOCARCINOMA; COLORECTAL CANCER; CONTROLLED STUDY; LIVER CELL; METASTASIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; CELL CULTURE; COCULTURE; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; COLORECTAL NEOPLASMS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HOMEODOMAIN PROTEINS; MALE; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; NEOPLASM METASTASIS; OSTEOPONTIN; RATS; SIALOGLYCOPROTEINS;

EID: 77954167894     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000672     Document Type: Article

References (28)

1. Soussi T: The p53 tumour suppressor gene: a model for molecular epidemiology of human cancer. Mol Med Today 2: 32-37, 1996. (Pubitemid 126408245)
2. Wanebo HJ, Semoglou C, Attiyeh F and Stearns MJ Jr: Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg 135: 81-85, 1978. (Pubitemid 8262964)
3. Choti MA, Sitzmann JV, Tiburi MF, et al: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: 759-766, 2002.
4. Fong Y, Fortner J, Sun RL, Brennan MF and Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-321, 1999. (Pubitemid 30191861)
5. Scheele J, Stang R, Altendorf-Hofmann A and Paul M: Resection of colorectal liver metastases. World J Surg 19: 59-71, 1995.
6. Zacharias T, Jaeck D, Oussoultzoglou E, Bachellier P and Weber JC: First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg 240: 858-865, 2004. (Pubitemid 39425780)
7. Koch M, Weitz J, Kienle P, et al: Comparative analysis of tumor cell dissemination in mesenteric, central, and peripheral venous blood in patients with colorectal cancer. Arch Surg 136: 85-89, 2001. (Pubitemid 32064126)
8. Stetler-Stevenson WG, Aznavoorian S and Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573, 1993. (Pubitemid 2021155)
9. Obrink B: Hepatocyte-collagen adhesion. Methods Enzymol 82A: 513-529, 1982.
10. Agrawal D, Chen T, Irby R, et al: Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 94: 513-521, 2002. (Pubitemid 34411290)
11. Sodek J, Ganss B and McKee MD: Osteopontin. Crit Rev Oral Biol Med 11: 279-303, 2000.
12. Fedarko NS, Jain A, Karadag A and Fisher LW: Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J 18: 734-736, 2004.
13. De Vita G, Barba P, Odartchenko N, et al: Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer 29A: 887-893, 1993.
14. Lei H, Wang H, Juan AH and Ruddle FH: The identification of Hoxc8 target genes. Proc Natl Acad Sci USA 102: 2420-2424, 2005.
15. Shi X, Yang X, Chen D, Chang Z and Cao X: Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J Biol Chem 274: 13711-13717, 1999. (Pubitemid 129518592)
16. Barnes GL, Javed A, Waller SM, et al: Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 63: 2631-2637, 2003.
17. Wai PY, Mi Z, Gao C, Guo H, Marroquin C and Kuo PC: Ets-1 and runx2 regulate transcription of a metastatic gene, osteopontin, in murine colorectal cancer cells. J Biol Chem 281: 18973-18982, 2006. (Pubitemid 44035400)
18. Fedarko NS, Fohr B, Robey PG, Young MF and Fisher LW: Factor H binding to bone sialoprotein and osteopontin enables tumor cell evasion of complement-mediated attack. J Biol Chem 275: 16666-16672, 2000. (Pubitemid 30398895)
19. Karadag A, Ogbureke KU, Fedarko NS and Fisher LW: Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion. J Natl Cancer Inst 96: 956-965, 2004. (Pubitemid 38868142)
20. Zeng ZS and Guillem JG: Unique activation of matrix metalloproteinase-9 within human liver metastasis from colorectal cancer. Br J Cancer 78: 349-353, 1998.
21. Zeng ZS, Shu WP, Cohen AM and Guillem JG: Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin Cancer Res 8: 144-148, 2002.
22. Zeng ZS and Guillem JG: Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells. Br J Cancer 74: 1161-1167, 1996. (Pubitemid 26360102)
23. Brabletz T, Jung A, Dag S, Hlubek F and Kirchner T: beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol 155: 1033-1038, 1999. (Pubitemid 29488909)
24. Ito Y: Oncogenic potential of the RUNX gene family: overview. Oncogene 23: 4198-4208, 2004.
25. Lee KS, Kim HJ, Li QL, et al: Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20: 8783-8792, 2000.
26. Markowitz S, Wang J, Myeroff L, et al: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338, 1995.
27. Huang F, Newman E, Theodorescu D, Kerbel RS and Friedman E: Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid. Cell Growth Differ 6: 1635-1642, 1995.
28. Padua D and Massague J: Roles of TGFbeta in metastasis. Cell Res 19: 89-102, 2009.